PPM1D inhibitor therapy(NOBO Medicine)

N/A

Report date: 2024/12/11 17:08:15

First In Class

Base Information

Drug NamePPM1D inhibitor therapy(NOBO Medicine)

Drug Alias NameProject 401

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein phosphatase 1D inhibitors

TargetsProtein phosphatase 1D

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNOBO Medicine Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A